Penserra Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,951
| Closed | -$426K | – | 1432 |
|
|
2023
Q4 | $426K | Buy |
+5,951
| New | +$426K | 0.01% | 563 |
|
|
2023
Q2 | – | Sell |
-6,876
| Closed | -$372K | – | 1341 |
|
|
2023
Q1 | $372K | Buy |
+6,876
| New | +$372K | 0.01% | 568 |
|
|
2021
Q4 | – | Sell |
-1,860
| Closed | -$69K | – | 1579 |
|
|
2021
Q3 | $69K | Buy |
1,860
+10
| +0.5% | +$371 | ﹤0.01% | 953 |
|
|
2021
Q2 | $75K | Buy |
1,850
+20
| +1% | +$811 | ﹤0.01% | 885 |
|
|
2021
Q1 | $62K | Sell |
1,830
-10
| -0.5% | -$339 | ﹤0.01% | 785 |
|
|
2020
Q4 | $58K | Buy |
1,840
+1,266
| +221% | +$39.9K | ﹤0.01% | 675 |
|
|
2020
Q3 | $14K | Buy |
+574
| New | +$14K | ﹤0.01% | 785 |
|